Cocrystal Pharma Reports Financial Results and Updates on Antiviral Drug-Development ProgramsOn November 13, 2024, Cocrystal Pharma, Inc. (NASDAQ: COCP) provided an overview of its financial results for the third quarter of 2024 and delivered updates
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cocrystal Pharma’s 8K filing here. Cocrystal Pharma Company Profile (Get Free Report) Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic […]
More Stories
CVS Health Co. (NYSE:CVS) Shares Bought by Seizert Capital Partners LLC
Seizert Capital Partners LLC raised its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 3.5% during...
PepsiCo, Inc. (NASDAQ:PEP) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC reduced its holdings in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 2.5%...
AM Squared Ltd Has $94,000 Stock Holdings in Target Co. (NYSE:TGT)
AM Squared Ltd trimmed its position in shares of Target Co. (NYSE:TGT – Free Report) by 50.0% during the third...
Marathon Trading Investment Management LLC Purchases New Position in T-Mobile US, Inc. (NASDAQ:TMUS)
Marathon Trading Investment Management LLC acquired a new stake in shares of T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) in...
BMO Capital Markets Forecasts Strong Price Appreciation for Mastercard (NYSE:MA) Stock
Mastercard (NYSE:MA – Free Report) had its price target lifted by BMO Capital Markets from $550.00 to $565.00 in a...
Torex Gold Resources Inc. (TSE:TXG) Director Caroline Donally Purchases 500 Shares
Torex Gold Resources Inc. (TSE:TXG – Get Free Report) Director Caroline Donally acquired 500 shares of the company’s stock in...